In contrast to the standardized microbial and mammalian cell platforms
embraced by the biopharmaceutical industry, there are many different plant-based expression systems
vying for attention, and those with the greatest potential to provide inexpensive biopharmaceuticals are also
the ones with the most significant drawbacks in terms of DSP.